298 related articles for article (PubMed ID: 34771575)
61. ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway.
Larrivée B; Prahst C; Gordon E; del Toro R; Mathivet T; Duarte A; Simons M; Eichmann A
Dev Cell; 2012 Mar; 22(3):489-500. PubMed ID: 22421041
[TBL] [Abstract][Full Text] [Related]
62. Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies.
Nolan-Stevaux O; Zhong W; Culp S; Shaffer K; Hoover J; Wickramasinghe D; Ruefli-Brasse A
PLoS One; 2012; 7(12):e50920. PubMed ID: 23300529
[TBL] [Abstract][Full Text] [Related]
63. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells.
Luo J; Tang M; Huang J; He BC; Gao JL; Chen L; Zuo GW; Zhang W; Luo Q; Shi Q; Zhang BQ; Bi Y; Luo X; Jiang W; Su Y; Shen J; Kim SH; Huang E; Gao Y; Zhou JZ; Yang K; Luu HH; Pan X; Haydon RC; Deng ZL; He TC
J Biol Chem; 2010 Sep; 285(38):29588-98. PubMed ID: 20628059
[TBL] [Abstract][Full Text] [Related]
64. De novo cerebrovascular malformation in the adult mouse after endothelial Alk1 deletion and angiogenic stimulation.
Chen W; Sun Z; Han Z; Jun K; Camus M; Wankhede M; Mao L; Arnold T; Young WL; Su H
Stroke; 2014 Mar; 45(3):900-2. PubMed ID: 24457293
[TBL] [Abstract][Full Text] [Related]
65. Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy.
Wu JB; Tang YL; Liang XH
Onco Targets Ther; 2018; 11():6901-6909. PubMed ID: 30410348
[TBL] [Abstract][Full Text] [Related]
66. EGFL7 Mediates BMP9-Induced Sprouting Angiogenesis of Endothelial Cells Derived from Human Embryonic Stem Cells.
Richter A; Alexdottir MS; Magnus SH; Richter TR; Morikawa M; Zwijsen A; Valdimarsdottir G
Stem Cell Reports; 2019 Jun; 12(6):1250-1259. PubMed ID: 31155507
[TBL] [Abstract][Full Text] [Related]
67. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
[TBL] [Abstract][Full Text] [Related]
68. Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation.
Herrera B; van Dinther M; Ten Dijke P; Inman GJ
Cancer Res; 2009 Dec; 69(24):9254-62. PubMed ID: 19996292
[TBL] [Abstract][Full Text] [Related]
69. Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression.
Yoshimatsu Y; Lee YG; Akatsu Y; Taguchi L; Suzuki HI; Cunha SI; Maruyama K; Suzuki Y; Yamazaki T; Katsura A; Oh SP; Zimmers TA; Lee SJ; Pietras K; Koh GY; Miyazono K; Watabe T
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18940-5. PubMed ID: 24133138
[TBL] [Abstract][Full Text] [Related]
70. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling.
Seki T; Yun J; Oh SP
Circ Res; 2003 Oct; 93(7):682-9. PubMed ID: 12970115
[TBL] [Abstract][Full Text] [Related]
71. Identification of the First Selective Activin Receptor-Like Kinase 1 Inhibitor, a Reversible Version of L-783277.
Cho H; Sengupta S; Jeon SS; Hur W; Choi HG; Seo HS; Lee BJ; Kim JH; Chung M; Jeon NL; Kim ND; Sim T
J Med Chem; 2017 Feb; 60(4):1495-1508. PubMed ID: 28103025
[TBL] [Abstract][Full Text] [Related]
72. Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia.
Ardelean DS; Letarte M
Front Genet; 2015; 6():35. PubMed ID: 25717337
[TBL] [Abstract][Full Text] [Related]
73. Trends and Challenges in Tumor Anti-Angiogenic Therapies.
Jászai J; Schmidt MHH
Cells; 2019 Sep; 8(9):. PubMed ID: 31540455
[TBL] [Abstract][Full Text] [Related]
74. Activin-like kinase receptor 1 (ALK1) in atherosclerotic lesions and vascular mesenchymal cells.
Yao Y; Zebboudj AF; Torres A; Shao E; Boström K
Cardiovasc Res; 2007 May; 74(2):279-89. PubMed ID: 17074310
[TBL] [Abstract][Full Text] [Related]
75. A Bone Morphogenetic Protein (BMP)-derived Peptide Based on the Type I Receptor-binding Site Modifies Cell-type Dependent BMP Signalling.
Tong Z; Guo J; Glen RC; Morrell NW; Li W
Sci Rep; 2019 Sep; 9(1):13446. PubMed ID: 31530856
[TBL] [Abstract][Full Text] [Related]
76. Stable tumor vessel normalization with pO₂ increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment.
Kieda C; El Hafny-Rahbi B; Collet G; Lamerant-Fayel N; Grillon C; Guichard A; Dulak J; Jozkowicz A; Kotlinowski J; Fylaktakidou KC; Vidal A; Auzeloux P; Miot-Noirault E; Beloeil JC; Lehn JM; Nicolau C
J Mol Med (Berl); 2013 Jul; 91(7):883-99. PubMed ID: 23471434
[TBL] [Abstract][Full Text] [Related]
77. Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer.
Harry JA; Ormiston ML
Front Oncol; 2021; 11():772305. PubMed ID: 34926282
[TBL] [Abstract][Full Text] [Related]
78. Nanoparticle Delivery and Tumor Vascular Normalization: The Chicken or The Egg?
Mattheolabakis G; Mikelis CM
Front Oncol; 2019; 9():1227. PubMed ID: 31799190
[TBL] [Abstract][Full Text] [Related]
79. Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization.
Li Y; Fu L; Wu B; Guo X; Shi Y; Lv C; Yu Y; Zhang Y; Liang Z; Zhong C; Han S; Xu F; Tian Y
Cancer Cell Int; 2023 Sep; 23(1):189. PubMed ID: 37660019
[TBL] [Abstract][Full Text] [Related]
80. The Role of a Lung Vascular Endothelium Enriched Gene TMEM100.
Pan J; Liu B; Dai Z
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
